Trends in the Use and Role of Biomarkers in Phase I Oncology TrialsBernardo H. L. Goulart, Bruce A. Chabner, Stan N. Finkelstein et al.|Clinical Cancer Research|2007Cited by 113
Economic Evaluation of a Bayesian Model to Predict Late-Phase Success of New Chemical EntitiesAsher D. Schachter, Stanley N Finkelstein, Marco Ramoni et al.|Value in Health|2007Cited by 9